A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease

A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease

NCT03976115 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous Nephropathy

NCT05136456 ·Status: UNKNOWN ·Phase: PHASE2

Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus

NCT06446310 ·Status: RECRUITING ·Phase: PHASE3

Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects

NCT05638126 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV

NCT04913272 ·Status: SUSPENDED ·Phase: PHASE2

A Study of GSK4771261 in Healthy Participants Aged 25 to 55 Years of Age Inclusive

NCT07600450 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Test the Safety and Blood Levels of PMG1016 in Healthy Adults

NCT07615985 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease

NCT06522997 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease

NCT05687890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Rollover Extension Clinical Trial To Evaluate The Long-Term Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With CKD IV Completing The US-APR2020-01 Study

NCT05407389 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

NCT03864458 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease

NCT06248567 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body, How it Moves Into, Through and Out of the Body When Single and Multiple Amounts Are Taken as Tablets in Japanese Healthy Male Participants

NCT05800444 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

NCT05593575 ·Status: COMPLETED ·Phase: PHASE2

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers

NCT00733265 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Pentoxifylline on Chronic Kidney Disease

NCT00155246 ·Status: COMPLETED ·Phase: PHASE4

Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria

NCT05718375 ·Status: COMPLETED ·Phase: PHASE2

A Phase I Clinical Trial to Evaluate CMS-D017 Following Single and Multiple Doses in Healthy Participants

NCT07462780 ·Status: RECRUITING ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants

NCT06727396 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis

NCT05624723 ·Status: COMPLETED ·Phase: PHASE1

Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease

NCT02177786 ·Status: COMPLETED ·Phase: PHASE2

End-stage Renal Disease (ESRD) Pilot Study

NCT03787368 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease

NCT02837237 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability and PK of SK-08

NCT07021157 ·Status: RECRUITING ·Phase: PHASE1

A Study to Assess S-217622 in Participants With Renal Impairment and Healthy Participants

NCT05363215 ·Status: COMPLETED ·Phase: PHASE1